Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer

ACS Nano

Volumn 8, Issue 7, 2014, Pages 6620-6632

  Wang, Dongsheng ^a   Fei, Baowei ^a,d   Halig, Luma V ^a   Qin, Xulei ^d   Hu, Zhongliang ^a   Xu, Hong ^b   Wang, Yongqiang Andrew ^b   Chen, Zhengjia ^a,c   Kim, Sungjin ^c   Shin, Dong M ^a   Chen, Zhuo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCEAN NANOTECH LLC   (United States)

^c EMORY UNIVERSITY   (United States)

^d Emory University   (United States)

Author keywords

Fmp IO Pc 4; head and neck cancer; integrin 1; iron oxide nanoparticle; magnetic resonance imaging; photodynamic therapy

Indexed keywords

BIOLOGICAL MATERIALS; BIOMIMETICS; DRUG DOSAGE; IRON OXIDES; LIGANDS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; PHOTODYNAMIC THERAPY; TOXICITY; TUMORS;

ANTI-CANCER THERAPIES; CARBOXYL-FUNCTIONALIZED; FMP-IO-PC 4; HEAD-AND-NECK CANCER; INHIBITION OF TUMOR GROWTH; INTEGRINS; PHOTODYNAMIC THERAPY (PDT); TARGETED NANOPARTICLE;

DISEASES;

BETA1 INTEGRIN; DRUG CARRIER; FERRIC ION; FERRIC OXIDE; FIBRONECTIN; INDOLE DERIVATIVE; NANOPARTICLE; ORGANOSILICON DERIVATIVE; PEPTIDOMIMETIC AGENT; SILICON PHTHALOCYANINE;

ANIMAL; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION; CHEMISTRY; DIAGNOSTIC USE; HEAD AND NECK NEOPLASMS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHOTOCHEMOTHERAPY;

ANIMALS; ANTIGENS, CD29; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DRUG CARRIERS; FERRIC COMPOUNDS; FIBRONECTINS; HEAD AND NECK NEOPLASMS; HUMANS; INDOLES; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR TARGETED THERAPY; NANOPARTICLES; ORGANOSILICON COMPOUNDS; PEPTIDOMIMETICS; PHOTOCHEMOTHERAPY;

EID: 84904732063     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn501652j     Document Type: Article

References (74)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer Statistics Ca-Cancer J. Clin. 2013, 63, 11-30
2. Jermal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Forman, D. Global Cancer Statistics Ca-Cancer J. Clin. 2011, 61, 69-90
3. Molin, Y.; Fayette, J. Current Chemotherapies for Recurrent/Metastatic Head and Neck Cancer Anticancer Drugs 2011, 22, 621-625
4. Shin, D. M.; Khuri, F. R. Advances in the Management of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Head Neck 2013, 35, 443-453
5. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic Therapy for Cancer Nat. Rev. Cancer 2003, 3, 380-387
6. Hahn, S. M.; Smith, R. P.; Friedberg, J. Photodynamic Therapy for Mesothelioma Curr. Treat. Options Oncol. 2001, 2, 375-383
7. Oleinick, N. L.; Morris, R. L.; Belichenko, I. The Role of Apoptosis in Response to Photodynamic Therapy: What, Where, Why, and How Photochem. Photobiol. Sci. 2002, 1, 1-21
8. Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D. et al. Photodynamic Therapy of Cancer: an Update Ca-Cancer J. Clin. 2011, 61, 250-281
9. Idris, N. M.; Gnanasammandhan, M. K.; Zhang, J.; Ho, P.; Mahendran, R.; Zhang, Y. In Vivo Photodynamic Therapy Using Upconversion Nanoparticles as Remote-controlled Nanotransducers Nat. Med. 2012, 18, 1580-1585
10. Civantos, F. Photodynamic Therapy for Head and Neck Lesions in the subtropics J. Natl. Compr. Cancer Network 2012, 10 (suppl2s) s65-s68
11. Jerjes, W.; Upile, T.; Hamdoon, Z.; Alexander Mosse, C.; Morcos, M.; Hopper, C. Photodynamic Therapy Outcome for T1/T2 N0 Oral Squamous Cell Carcinoma Lasers Surg. Med. 2011, 43, 463-469
12. Biel, M. A. Photodynamic Therapy of Head and Neck Cancers Methods Mol. Biol. 2010, 635, 281-293
13. Rigual, N. R.; Thankappan, K.; Cooper, M.; Sullivan, M. A.; Dougherty, T.; Popat, S. R.; Loree, T. R.; Biel, M. A.; Henderson, B. Photodynamic Therapy for Head and Neck Dysplasia and Cancer Arch. Otolaryngol., Head Neck Surg. 2009, 135, 784-788
14. He, J.; Larkin, H. E.; Li, Y. S.; Rihter, B. S.; Zaidi, S.; Rodgers, M. A.; Mukhtar, H.; Kenney, M. E.; Oleinick, N. L. The Synthesis, Photophysical and Photobiological Properties and In Vitro Structure-Activity Relationships of a Set of Silicon Phthalocyanine PDT Photosensitizers Photochem. Photobiol. 1997, 65, 581-586
15. Baron, E. D.; Malbasa, C. L.; Santo-Domingo, D.; Fu, P.; Miller, J. D.; Hanneman, K. K.; Hsia, A. H.; Oleinick, N. L.; Colussi, V. C.; Cooper, K. D. Silicon Phthalocyanine (Pc 4) Photodynamic Therapy is a Safe Modality for Cutaneous Neoplasms: Results of a Phase 1 Clinical Trial Lasers Surg. Med. 2010, 42, 728-735
16. Lee, T. K.; Baron, E. D.; Foster, T. H. Monitoring Pc 4 Photodynamic Therapy in Clinical Trials of Cutaneous T-Cell Lymphoma Using Noninvasive Spectroscopy J. Biomed. Opt. 2008, 13, 030507
17. Wang, H.; Fei, B. Diffusion-Weighted MRI for Monitoring Tumor Response to Photodynamic Therapy J. Magn. Reson. Imaging 2010, 32, 409-417
18. Fei, B.; Wang, H.; Wu, C.; Chiu, S. M. Choline PET for Monitoring Early Tumor Response to Photodynamic Therapy J. Nucl. Med. 2010, 51, 130-138
19. Fei, B.; Wang, H.; Wu, C.; Meyers, J.; Xue, L. Y.; Maclennan, G.; Schluchter, M. Choline Molecular Imaging with Small-Animal PET for Monitoring Tumor Cellular Response to Photodynamic Therapy of Cancer Proc. SPIE 2009, 7262, 1-11
20. Cheng, Y.; Samia, A. C.; Meyers, J. D.; Panagopoulos, I.; Fei, B.; Burda, C. Highly Efficient Drug Delivery with Gold Nanoparticle Vectors for In Vivo Photodynamic Therapy of Cancer J. Am. Chem. Soc. 2008, 130, 10643-10647
21. Fei, B.; Wang, H.; Meyers, J. D.; Feyes, D. K.; Oleinick, N. L.; Duerk, J. L. High-Field Magnetic Resonance Imaging of the Response of Human Prostate Cancer to Pc 4-Based Photodynamic Therapy in an Animal Model Lasers Surg. Med. 2007, 39, 723-730
22. Fei, B.; Wang, H.; Muzic, R. F., Jr.; Flask, C.; Wilson, D. L.; Duerk, J. L.; Feyes, D. K.; Oleinick, N. L. Deformable and Rigid Registration of MRI and MicroPET Images for Photodynamic Therapy of Cancer in Mice Med. Phys. 2006, 33, 753-760
23. Davis, E. D.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 772-783
24. Lee, S. J.; Lee, H. J.; Moon, M. J.; Vu-Quang, H.; Lee, H. J.; Muthiah, M.; Che, H. L.; Heo, S. U.; Jeong, H. J.; Jeong, Y. Y. et al. Superparamagnetic Iron Oxide Nanoparticles-Loaded Polymersome-Mediated Gene Delivery Guided by Enhanced Magnetic Resonance Signal J. Nanosci. Nanotechnol. 2011, 11, 7057-7060
25. Hayashi, K.; Nakamura, M.; Sakamoto, W.; Yogo, T.; Miki, H.; Ozaki, S.; Abe, M.; Matsumoto, T.; Ishimura, K. Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment Theranostics 2013, 3, 366-376
26. Fang, C.; Veiseh, O.; Kievit, F.; Bhattarai, N.; Wang, F.; Stephen, Z.; Li, C.; Lee, D.; Ellenbogen, R. G.; Zhang, M. Functionalization of Iron Oxide Magnetic Nanoparticles with Targeting Ligands: Their Physicochemical Properties and In Vivo Behavior Nanomedicine (London, U. K.) 2010, 5, 1357-1369
27. He, H.; David, A.; Chertok, B.; Cole, A.; Lee, K.; Zhang, J.; Wang, J.; Huang, Y.; Yang, V. C. Magnetic Nanoparticles for Tumor Imaging and Therapy: A So-Called Theranostic System Pharm. Res. 2013, 30, 2445-2458
28. Choi, H. S.; Frangioni, J. V. Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation Mol. Imaging 2010, 9, 291-310
29. Tassa, C.; Shaw, S. Y.; Weissleder, R. Dextran-Coated Iron Oxide Nanoparticles: A Versatile Platform for Targeted Molecular Imaging, Molecular Diagnostics, and Therapy Acc. Chem. Res. 2011, 44, 842-852
30. Wu, C.; Bauer, J. S.; Juliano, R. L.; McDonald, J. A. The Alpha 5 Beta 1Integrin Fibronectin Receptor, but not the Alpha 5 Cytoplasmic Domain, Functions in an Early and Essential Step in Fibronectin Matrix Assembly J. Biol. Chem. 1993, 268, 21883-21888
31. Van Waes, C.; Surth, D. M.; Chen, Z.; Kirby, M.; Rhim, J. S.; Brager, R.; Sessions, R. B.; Poore, J.; Wolf, G. T.; Carey, T. E. Increase in Suprabasilar Integrin Adhesion Molecule Expression in Human Epidermal Neoplasms Accompanies Increased Proliferation Occurring with Immortalization and Tumor Progression Cancer Res. 1995, 55, 5434-5444
32. Eke, I.; Deuse, Y.; Hehlgans, S.; Gurtner, K.; Krause, M.; Baumann, M.; Shevchenko, A.; Sandfort, V.; Cordes, N. β1 Integrin/FAK/Cortactin Signaling is Essential for Human Head and Neck Cancer Resistance to Radiotherapy J. Clin. Invest. 2012, 122, 1529-1540
33. Wang, D.; Muller, S.; Amin, A. R.; Huang, D.; Su, L.; Hu, Z.; Rahman, M. A.; Koenig, L.; Chen, Z.; Tighiouart, T. et al. The Pivotal Role of Integrinb1 in Metastasis of Head and Neck Squamous Cell Carcinoma Clin. Cancer Res. 2012, 18, 4589-4599
34. Mardilovich, A.; Craig, J. A.; McCammon, M. Q.; Garg, A.; Kokkoli, E. Design of a Novel Fibronectin-Mimetic Peptide-Amphiphile for Functionalized Biomaterials Langmuir 2006, 22, 3259-3264
35. Garg; Kokkoli, E. pH-Sensitive PEGylated Liposomes Functionalized with a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cell Curr. Pharm. Biotechnol. 2011, 12, 1135-1143
36. Flors, C.; Fryer, M. J.; Waring; Reeder, B.; Bechtold, U.; Mullineaux, P. M.; Nonell, S.; Wilson, M. T.; Baker, N. R. Imaging the Production of Singlet Oxygen In Vivo Using A New Fluorescent Sensor, Singlet Oxygen Sensor Green J. Exp. Bot. 2006, 57, 1725-1734
37. Yano, T.; Muto, M.; Minashi, K.; Iwasaki, J.; Kojima, T.; Fuse, N.; Doi, T.; Kaneko, K.; Ohtsu, A. Photodynamic Therapy as Salvage Treatment for Local Failure after Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma: A Phase II Study Int. J. Cancer 2012, 131, 1228-1234
38. Egorin, M. J.; Zuhowski, E. G.; Sentz, D. L.; Dobson, J. M.; Callery, P. S.; Eiseman, J. L. Plasma Pharmacokinetics and Tissue Distribution in CD2F1Mice of Pc4 (NSC 676418), A Silicone Phthalocyanine Photodynamic Sensitizing Agent Cancer Chemother. Pharmacol. 1999, 44, 283-294
39. Miller, J. D.; Baron, E. D.; Scull, H.; Hsia, A.; Berlin, J. C.; McCormick, T.; Colussi, V.; Kenney, M. E.; Cooper, K. D.; Oleinick, N. L. Photodynamic Therapy with the Phthalocyanine Photosensitizer Pc 4: the Case Experience with Preclinical Mechanistic and Early Clinical-Translational Studies Toxicol. Appl. Pharmacol. 2007, 224, 290-299
40. Werner, M. E.; Copper, J. A.; Karve, S.; Cummings, N. D.; Sukumar, R.; Li, C.; Napier, M. E.; Chen, R. C.; Cox, A. D.; Wang, A. Z. Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy ACS Nano 2011, 5, 8990-8998
41. Master, A. M.; Qi, Y.; Oleinick, N. L.; Gupta, A. S. EGFR-Mediated Intracellular Delivery of Pc 4 Nanoformulation for Targeted Photodynamic Therapy of Cancer: In Vitro Studies Nanomedicine 2012, 8, 655-664
42. Li, P.; Zhao, Z.j.; Liu, F. Y.; Sun, L. Y.; Ding, X.; Zhang, W. Z. Chemokine Receptor 7 Regulates Cell Adhesion and Migration via Beta1 Integrin in Metastatic Squamous Cell Carcinoma of the Head and Neck Oncol. Rep. 2010, 24, 988-995
43. Atchison, N. A.; Fan, W.; Papas, K. K.; Hering, B. J.; Tsapatsis, M.; Kokkoli, E. Binding of the Fibronectin-Mimetic Peptide, PR-b, to Alpha5Beta1 on Pig Islet Cells Increases Fibronectin Production and Facilitates Internalization of PR-b Functionalized Liposomes Langmuir 2010, 26, 14081-14088
44. Pangburn, T. O.; Georgiou, K.; Bates, F. S.; Kokkoli, E. Targeted Polymersome Delivery of siRNA Induces Cell Death of Breast Cancer Cells Dependent upon Orai3 Protein Expression Langmuir 2012, 28, 12816-12830
45. Beech, J. R.; Shin, S. J.; Smith, J. A.; Kelly, K. A. Mechanisms for Targeted Delivery of Nanoparticles in Cancer Curr. Pharm. Des. 2013, 19, 6560-6574
46. Singh, S.; Sharma, A.; Robertson, G. P. Realizing the Clinical Potential of Cancer Nanotechnology by Minimizing Toxicologic and Targeted Delivery Concerns Cancer Res. 2012, 72, 5663-5668
47. Xu, S.; Olenyuk, B. Z.; Okamoto, C. T.; Hamm-Alvarez, S. F. Targeting Receptor-Mediated Endocytotic Pathways with Nanoparticles: Rationale and Advances Adv. Drug Delivery Rev. 2013, 65, 121-138
48. Master, A. M.; Livingston, M.; Oleinick, N. L.; Sen Gupta, A. Optimization of a Nanomedicine-Based Silicon Phthalocyanine 4 Photodynamic Therapy (Pc 4-PDT) Strategy for Targeted Treatment of EGFR-Overexpressing Cancers Mol. Pharm. 2012, 9, 2331-2338
49. Master, A.; Malamas, A.; Solanki, R.; Clausen, D. M.; Eiseman, J. L.; Sen Gupta, A. A Cell-Targeted Photodynamic Nanomedicine Strategy for Head and Neck Cancers Mol. Pharm. 2013, 10, 1988-1997
50. Mir, Y.; Elrington, S. A.; Hasan, T. A New Nanoconstruct for Epidermal Growth Factor Receptor-Targeted Photo-Immunotherapy of Ovarian Cancer Nanomedicine 2013, 9, 1114-1122
51. Li, W.; Lu, W.; Fan, Z.; Zhu, X.; Reed, A.; Newton, B.; Zhang, Y.; Courtney, S.; Tiyyagura, P. T.; Li, S. et al. Enhanced Photodynamic Selectivity of Nano-Silica-Attached Porphyrins Against Breast Cancer Cells J. Mater. Chem. 2012, 22, 12701-12708
52. Bao, G.; Mitragotri, S.; Tong, S. Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging Annu. Rev. Biomed. Eng. 2013, 15, 253-282
53. Le Duc, G.; Miladi, I.; Alric, C.; Mowat, P.; Bräuer-Krisch, E.; Bouchet, A.; Khalil, E.; Billotey, C.; Janier, M.; Lux, F. et al. Toward an Image-Guided Microbeam Radiation Therapy Using Gadolinium-Based Nanoparticles ACS Nano 2011, 5, 9566-9574
54. Yu, M. K.; Kim, D.; Lee, I. H.; So, J. S.; Jeong, Y. Y.; Jon, S. Image-Guided Prostate Cancer Therapy Using Aptamer-Functionalized Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles Small 2011, 7, 2241-2249
55. Pouliquen, D.; Perdrisot, R.; Ermias, A.; Akoka, S.; Jallet, P.; Le Jeune, J. J. Superparamagnetic Iron Oxide Nanoparticles as a Liver MRI Contrast Agent: Contribution of Microencapsulation to Improved Biodistribution Magn. Reson. Imaging 1989, 7, 619-627
56. Kumar, M.; Yigit, M.; Dai, G.; Moore, A.; Medarova, Z. Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug Cancer Res. 2010, 70, 7553-7561
57. Ling, D.; Hyeon, T. Iron Oxide Nanoparticles: Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications Small 2013, 9, 1450-1466
58. Sjogren, C. E.; Johansson, C.; Naevestad, A.; Sontum, P. C.; Briley-Saebo, K.; Fahlvik, A. K. Crystal Size and Properties of Superparamagnetic Iron Oxide (SPIO) Particles Magn. Reson. Imaging 1997, 15, 55-67
59. Wunderbaldinger, P.; Josephson, L.; Bremer, C.; Moore, A.; Weissleder, R. Detection of Lymph Node Metastases by Contrast-Enhanced MRI in an Experimental Model Magn. Reson. Med. 2002, 47, 292-297
60. Hogemann, D.; Josephson, L.; Weissleder, R.; Basilion, J. P. Improvement of MRI Probes to Allow Efficient Detection of Gene Expression Bioconjugate Chem. 2000, 11, 941-946
61. Bulte, J. W.; Kraitchman, D. L. Iron Oxide MR Contrast Agents for Molecular and Cellular Imaging NMR Biomed. 2004, 17, 484-99
62. Moore, A.; Weissleder, R.; Bogdanov, A., Jr. Uptake of Dextran-Coated Monocrystalline Iron Oxides in Tumor Cells and Macrophages J. Magn. Reson. Imaging 1997, 7, 1140-1145
63. Schultz, J. F.; Bell, J. D.; Goldstein, R. M.; Kuhn, J. A.; McCarty, T. M. Hepatic Tumor Imaging Using Iron Oxide MRI: Comparison with Computed Tomography, Clinical Impact, and Cost Analysis Ann. Surg. Oncol. 1999, 6, 691-698
64. Harisinghani, M. G.; Barentsz, J.; Hahn, P. F.; Deserno, W. M.; Tabatabaei, S.; van de Kaa, C. H.; de la Rosette, J.; Weissleder, R. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer N. Engl. J. Med. 2003, 348, 2491-2499
65. Kircher, M. F.; Allport, J. R.; Graves, E. E.; Love, V.; Josephson, L.; Lichtman, A. H.; Weissleder, R. In Vivo High Resolution Three-Dimensional Imaging of Antigen-Specific Cytotoxic T-Lymphocyte Trafficking to Tumors Cancer Res. 2003, 63, 6838-6846
66. Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X. W.; Cory, D.; Scadden, D. T.; Weissleder, R. Tat Peptide-Derivatized Magnetic Nanoparticles Allow In Vivo Tracking and Recovery of Progenitor Cells Nat. Biotechnol. 2000, 18, 410-414
67. Tang, M. F.; Lei, L.; Guo, S. R.; Huang, W. L. Recent Progress in Nanotechnology for Cancer Therapy Chin. J. Cancer 2010, 29, 775-780
68. Yamashita, K.; Yoshioka, Y.; Kayamuro, H.; Yoshida, T.; Higashisaka, K.; Abe, Y.; Yoshikawa, T.; Itoh, N.; Tsunoda, S.; Tsutsumi, Y. Cancer Hazard of Carbon Nanotubes: Size/Shape-Dependent Induction of DNA Damage and Inflammation Cytokine 2009, 48, 55-55
69. Buyukhatipoglu, K.; Clyne, A. M. Superparamagnetic Iron Oxide Nanoparticles Change Endothelial Cell Morphology and Mechanics via Reactive Oxygen Species Formation J. Biomed. Mater. Res., Part A 2011, 96, 186-195
70. Gilli, G.; Schiliro, T.; Traversi, D.; Pignata, C.; Cordara, S.; Carraro, E. Formaldehyde Adduct to Human Serum Albumin with Reference to Aspartame Intake Environ. Toxicol. Pharmacol. 2008, 25, 89-93
71. Higai, K.; Satake, M.; Nishioka, H.; Azuma, Y.; Matsumoto, K. Glycated Human Serum Albumin Enhances Macrophage Inflammatory Protein-1Beta mRNA Expression through Protein Kinase C-Delta and NADPH Oxidase in Macrophage-Like Differentiated U937 Cells Biochim. Biophys. Acta 2008, 1780, 307-314
72. Katavetin, P.; Inagi, R.; Miyata, T.; Tanaka, T.; Sassa, R.; Ingelfinger, J. R.; Fujita, T.; Nangaku, M. Albumin Suppresses Vascular Endothelial Growth Factor via Alteration of Hypoxia-Inducible Factor/Hypoxia-Responsive Element Pathway Biochem. Biophys. Res. Commun. 2008, 367, 305-310
73. Yokoe, J.; Sakuragi, S.; Yamamoto, K.; Teragaki, T.; Ogawara, K.; Higaki, K.; Katayama, N.; Kai, T.; Sato, M.; Kimura, T. Albumin-Conjugated PEG Liposome Enhances Tumor Distribution of Liposomal Doxorubicin in Rats Int. J. Pharm. 2008, 353, 28-34
74. Wang, D.; Su, L.; Huang, D.; Zhang, H.; Shin, D. M.; Chen, Z. G. Downregulation of E-Cadherin Enhances Proliferation of Head and Neck Cancer through Transcriptional Regulation of EGFR Mol. Cancer 2011, 10, 116